Silk Road Medical Partners with Genesis MedTech to Propel Healthcare Access in China

WUXI, China—In a landmark agreement that promises to change the face of medical care for carotid artery disease patients in China, Silk Road Medical, Inc. SILK, a pioneer in the development of medical devices headquartered in Sunnyvale, California, has announced an exclusive distribution partnership with Genesis MedTech Group. This strategic alliance aims to enhance the treatment options available to patients suffering from carotid artery disease by introducing pioneering technology to the Chinese market.

Combating Carotid Artery Disease

Carotid artery disease remains a significant health concern in China, leading to potentially severe complications such as strokes. The partnership between SILK and Genesis MedTech Group aims to bring the innovative TCAR® (TransCarotid Artery Revascularization) procedure to Chinese patients. This technique is less invasive compared to traditional methods and has been designed to reduce the risk of stroke during the treatment of blockages in the carotid artery.

Advancing Medical Technology Access

Under the new deal, Genesis MedTech Group becomes the exclusive distributor of SILK's core products in the region: the ENROUTE® Transcarotid Neuroprotection System and the ENROUTE® Stent. The Neuroprotection System safeguards patients against stroke by temporarily reversing blood flow in the carotid artery during the procedure, while the stent is integral to the long-term success of the TCAR® procedure in opening up clogged arteries.

The Potential Impact on Chinese Healthcare

The expansion of SILK's revolutionary medical technology into China, facilitated by Genesis MedTech Group, could significantly improve the quality of life for countless individuals and potentially reduce the overall incidence of strokes in the country. By offering this cutting-edge treatment option, the companies are jointly contributing to the advancement of the Chinese healthcare system and setting a new standard of care for carotid artery disease patients.

healthcare, technology, partnership